Concepedia

Publication | Open Access

Response to eculizumab in patients with myasthenia gravis recently treated with chronic IVIg: a subgroup analysis of REGAIN and its open-label extension study

DOIFull Paper Access

26

Citations

7

References

2020

Year

Saiju Jacob, Hiroyuki Murai, Kimiaki Utsugisawa, Richard J. Nowak, Heinz Wiendl, Kenji P. Fujita, Fanny O’Brien, James F. Howard, Claudio Mazia, Miguel Wilken,
Therapeutic Advances in Neurological Disorders

Abstract

REGAIN [ClinicalTrials.gov identifier: NCT01997229]; REGAIN open-label extension [ClinicalTrials.gov identifier: NCT02301624].

References

YearCitations

Page 1